MARKET

TLSIW

TLSIW

TriSalus Life Sciences Inc.
NASDAQ
0.8798
0.0000
0.00%
Closed 09:30 07/13 EDT
OPEN
0.8798
PREV CLOSE
0.8798
HIGH
0.8798
LOW
0.8798
VOLUME
3.24K
TURNOVER
--
52 WEEK HIGH
5.000
52 WEEK LOW
0.4405
MARKET CAP
--
P/E (TTM)
-0.6239
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TLSI last week (0706-0710)?
Weekly Report · 16h ago
Weekly Report: what happened at TLSI last week (0629-0703)?
Weekly Report · 07/06 09:35
QuidelOrtho (QDEL) Moves 32.2% Higher: Will This Strength Last?
NASDAQ · 06/30 11:59
TriSalus Life Sciences names Richard Henry Marshall as chief medical officer in initial beneficial ownership filing
PUBT · 06/29 20:31
Weekly Report: what happened at TLSI last week (0622-0626)?
Weekly Report · 06/29 09:33
Analysts’ Top Healthcare Picks: TriSalus Life Sciences (TLSI), CAMP4 Therapeutics Corporation (CAMP)
TipRanks · 06/25 13:10
Analysts Offer Insights on Healthcare Companies: Owlet (OWLT), Phreesia (PHR) and TriSalus Life Sciences (TLSI)
TipRanks · 06/25 11:20
Quantum Healthcare reallocates S$3 million placement proceeds to split funding between working capital, MedTech M&A
PUBT · 06/23 13:21
More
About TLSIW
TriSalus Life Sciences, Inc. is an oncology-focused medical technology company. It is seeking to transform outcomes for patients with solid tumors by integrating its delivery technology with standard-of-care therapies, and with its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 agonist, for a range of different therapeutic and technological applications. Its delivery method, Pressure-Enabled Drug Delivery (PEDD), modulates pressure and flow within blood vessels to improve intravascular therapeutic delivery into tumors, thereby increasing the likelihood of tumor response in comparison to conventional delivery technologies. Its on-market TriNav Infusion System using PEDD technology, is being used for interventional radiology procedures, commonly transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or in patients with liver metastases. TriNav is a device with a novel (PEDD) delivery method.

Webull offers TriSalus Life Sciences Inc stock information, including NASDAQ: TLSIW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLSIW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TLSIW stock methods without spending real money on the virtual paper trading platform.